Among menopausal women who are overweight or obese, an intensive diet and exercise program can significantly reduce the incidence and severity of hot flushes, according to a trial.
Among menopausal women who are overweight or obese, an intensive diet and exercise program can significantly reduce the incidence and severity of hot flushes, according to a randomized, controlled trial led by researchers at the University of California, San Francisco.
The researchers used self-administered questionnaires to assess the hot flushes of 338 women who participated in either a 6-month intensive behavioral weight loss program (intervention) or a structured health education program (control).
Researchers found that for women who were at least slightly bothered by hot flushes at baseline, the intervention was more than twice as likely as the control to improve hot flushes by 1 Likert category (odds ratio [OR], 2.25; 95% confidence interval [CI], 1.20-4.21).
Reductions in weight (OR, 1.32; 95% CI, 1.08-1.61 per 5-kg decrease), body mass index (OR, 1.17; 95% CI, 1.05-1.30 per 1-point decrease), and abdominal circumference (OR, 1.32; 95% CI, 1.07-1.64 per 5-cm decrease) were similarly associated with improvement in flushing.
Changes in physical activity, calorie intake, blood pressure, and physical and mental functioning did not seem to make a difference in the incidence or severity of hot flushes, however.
Huang AJ, Subak LL, Wing R, et al. An intensive behavioral weight loss intervention and hot flushes in women. Arch Intern Med. 2010;170(13):1161-1167.
Severe maternal morbidity linked to mental health risks post-delivery
April 26th 2024A recent study revealed that severe maternal morbidity during pregnancy increases the likelihood of mental health hospitalizations or emergency department visits up to 13 years post-delivery, emphasizing the need for mental health screening.
Read More
FDA approves updated label for Biktarvy against HIV-1
April 26th 2024Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More